Compounds > fluconazole

fluconazole and micafungin

fluconazole has been researched along with micafungin in 151 studies

Research

Studies (151)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's59 (39.07)29.6817
2010's72 (47.68)24.3611
2020's20 (13.25)2.80

Authors

AuthorsStudies
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C2
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C1
Hashimoto, K; Kaeriyama, M; Kimura, A; Mitsuyama, J; Narita, H; Nishikawa, H; Nomura, N; Todo, Y; Yamada, E1
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL1
Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS1
Lombardo, F; Obach, RS; Waters, NJ1
Chu, CC; Hsueh, PR; Ruan, SY1
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS1
Dimopoulos, G; Falagas, ME; Velegraki, A1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL1
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE1
Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K1
Mitsuyama, J; Nishikawa, H; Nomura, N; Yamada, E1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Du, C; Ji, Q; Liu, L; Wu, H; Xu, Y; Zhou, X1
Nishiyama, Y; Uchida, K; Yamaguchi, H; Yokota, N1
Maesaki, S; Yamaguchi, T1
Yamaguchi, H1
Ikeda, F1
Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K1
Bujdáková, H; Melkusová, S; Mikami, Y; Myoken, Y; Volleková, A1
Baraldi, E; de Wet, N; Della Negra, M; Diekmann-Berndt, H; Krantz, EF; Llanos-Cuentas, A; Suleiman, J1
Asako, E; Harada, S; Majoros, L; Nishikawa, A; Ohkusu, M; Ohshima, F; Sipiczki, M; Sugita, T; Takashima, M; Takeo, K; Virtudazo, E; Yanaka, C1
Bunin, N; Hiemenz, JW; Lee, JM; Lipton, JH; Miller, CB; Ratanatharathorn, V; Satoi, Y; Stepan, DE; van Burik, JA; Vesole, DH; Wall, DA; Walsh, TJ1
Yoshida, M1
Marr, K1
Gilgado, F; Guarro, J; Mayayo, E; Pastor, FJ; Serena, C1
Mikamo, H; Ninomiya, M; Tamaya, T; Tanaka, K; Watanabe, K1
Buell, D; Cagnoni, P; Chao, N; Devine, S; Facklam, D; Hiemenz, J; Keirns, J; Lau, W; Simpson, D1
Bester, AJ; Buell, D; de Wet, NT; Filho, F; Fisco, C; Lau, W; Llanos, EA; Suleiman, JM; Ticona, E; Viljoen, JJ1
Cornely, OA; Karthaus, M; Ullmann, AJ1
Steinbach, WJ1
Niwa, T; Shiraga, T; Takagi, A1
Fernández-Torres, B; Guarro, J; Mariné, M; Pastor, FJ; Serena, C1
Kawasugi, K; Morimoto, T; Nomura, K1
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S1
Nakamura, K; Nakasone, I; Ohta, C; Onaga, S; Yamane, N1
Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K1
Iwasaki, H; Kinoshita, K; Ueda, T; Uzui, H1
Guarro, J; Mariné, M; Pastor, FJ; Serena, C1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C1
Hiraoka, T; Kaji, Y; Nanbu, PN; Okamoto, F; Oshika, T; Wakabayashi, T1
Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S1
Carrillo, A; Guarro, J; Pastor, FJ; Quindós, G; Rodríguez, MM; Ruiz, M1
Angiolella, L; Bonito, M; Cassone, A; Colone, M; De Bernardis, F; Palamara, AT; Posteraro, B; Sanguinetti, M; Stringaro, AR; Toccacieli, L; Torosantucci, A1
Asaka, M; Chiba, K; Fujisawa, F; Hashino, S; Izumiyama, K; Kahata, K; Kawamura, T; Kondo, T; Morita, L; Nakagawa, M; Onozawa, M; Takahata, M; Yonezumi, M1
Fothergill, A; Kirkpatrick, WR; Oliveira, ER; Patterson, TF; Redding, SW1
Schonfeld, W; Seifeldin, R; Tong, KB; Wang Cheng, J1
Chen, G; Ohashi, Y; Suzuki, T; Uno, T1
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L1
Asakura, S; Fujii, N; Hara, M; Hiramatsu, Y; Ikeda, K; Maeda, Y; Matsuo, K; Matsuoka, KI; Miyata, A; Nawa, Y; Saito, T; Shinagawa, K; Sunami, K; Tabayashi, T; Tanimoto, M; Yano, T1
Niimi, K; Niimi, M; Tanabe, K1
Imamura, Y; Izumikawa, K; Kohno, S1
Fujii, Y; Inase, N; Yoshizawa, Y1
Bland, CM; Thomas, S1
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M1
Salavert-Lletí, M; Zaragoza-Crespo, R1
Kim, D; Kim, J; Lee, TJ; Sohn, HS1
Kothari, S; Shorr, AF; Zilberberg, MD1
Golan, Y1
Higuchi, B; Hirano, S; Inoue, M; Ishihara, T; Kawa, K; Kondo, O; Kouroki, M; Koyama, M; Sakata, A; Sakata, N; Sawada, A; Takeshita, Y; Yasui, M; Yoshioka, A1
Afonso, L; Bhargava, A; Chopra, A; Chopra, T; Dhar, S; Kumar, S; Sobel, JD1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA1
Kojima, T; Matsumoto, Y; Murat, D; Shimazaki, J; Tsubota, K1
Churchwell, MD; Dotson, B1
Andes, D; Arendrup, MC; Brown, SD; Diekema, DJ; Lockhart, SR; Motyl, M; Perlin, DS; Pfaller, MA1
Cantón, E; Espinel-Ingroff, A1
Takakura, S1
Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K1
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M1
Katayama, N; Kohara, T; Kyo, T; Nakase, K; Sugawara, Y; Suzuki, K1
Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Morinaga, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K1
Chatterjee, S; Springer, J1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC1
Cho, T; Imayoshi, R; Kaminishi, H; Kodama, J; Morotomi, T; Nagao, J1
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L1
Murakami, H; Tashiro, M; Tateda, K; Yamaguchi, K; Yoshizawa, S1
Furuya, N; Mano, Y; Morishige, H; Oguri, T1
Hakariya, M; Kaneko, Y; Matsumoto, S; Miyagawa, S; Miyazaki, Y; Ohno, H; Takeda, O1
Angiolella, L; Celestino, I; Colone, M; Passariello, C; Stringaro, A; Toccacieli, L; Vavala, E1
Ibara, S; Inoue, T; Ishihara, C; Kodaira, Y; Maede, Y; Matsui, T; Nagasaki, H; Tokuhisa, T; Torikai, M1
Garcia, J; Horseman, MA; Matthew, E; Soch, K; Surani, S1
Casamayor, M; Masterton, RG; Musingarimi, P; Odeyemi, IA; Odufowora-Sita, O; van Engen, A; Zinck, R1
Hagiya, H; Kajioka, H1
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA1
Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C1
Kourbeti, IS; Mylonakis, E; Ziakas, PD1
Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K1
Gil-Gómez, I; Lorente-Fernández, L; Monte-Boquet, E; Poveda-Andrés, JL; Ruiz-Ramos, J; Salavert-Lleti, M1
Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J1
Green, JS; Leuck, AM; Rothenberger, MK1
Beldavs, ZG; Bolden, CB; Chiller, TM; Cleveland, AA; Farley, MM; Harrison, LH; Iqbal, N; Kuykendall, RJ; Lockhart, SR; Park, BJ; Pham, CD; Schaffner, W1
Angiolella, L; Colone, M; Dupré, S; Macone, A; Maras, B; Mignogna, G; Palamara, AT; Pitari, G; Stringaro, A; Vavala, E1
Bray, N; Osman, A; Rivera, NT; Vicuña, R; Wang, H; Zelnick, K1
Arnold, H; Hampton, N; Juang, P; Kollef, M; McKenzie, M; Micek, ST; Scolarici, M1
Cornely, OA; Franke, B; Glossmann, J; Heimann, SM; Kochanek, M; Langebartels, G; Padosch, SA; Reiner, M; Reuter, H; Seifert, H; Stippel, D; Vehreschild, JJ; Vehreschild, MJ; Vierzig, A; Wisplinghoff, H1
Asano, M; Inagaki, K; Ito, Y; Kaneko, Y; Kariya, T; Masamoto, D; Miyazaki, Y; Mizuno, M; Mizutani, M; Nagahara, Y; Ohno, H; Urai, M1
Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA1
Kawai, A; Mikamo, H; Yamagishi, Y1
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF1
Auzinger, G; Charbonneau, C; Graham, CN; Kantecki, M; Knox, HN; Playford, EG; Schlamm, H; Weinstein, D1
Hall, RG; Payne, KD1
Groeneveld, AB; Rijnders, BJ; van der Geest, PJ; Vonk, AG1
Feng, B; Shen, JL; Tang, XF; Xu, HQ; Xu, SX1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ1
Chung, DR; Jang, JH; Jung, CW; Kang, CI; Kim, K; Kim, SJ; Kim, WS; Park, S; Peck, KR1
Hsueh, PR; Wang, H; Xu, YC1
Burns, MJ; Kesler, KA; Langdorf, MI1
Barber, KE; Cretella, D; King, ST; Stover, KR1
Aurbach, U; Cornely, OA; De Hoog, S; Demeter, J; Durán Graeff, L; Hamprecht, A; Kindo, A; Racil, Z; Seidel, D; Vehreschild, MJ; Wisplinghoff, H; Ziegler, M1
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K1
Charbonneau, C; Chen, YC; Lee, TY; Ou, HT1
Izumikawa, K; Kohno, S; Minematsu, A; Miyazaki, T; Mukae, H; Nagayoshi, Y; Nakamura, S; Nakayama, H; Shimamura, S; Takazono, T; Yamauchi, S; Yanagihara, K1
Almeida-Paes, R; Barbedo, LS; de Oliveira, JCA; Dos Santos, ALS; Figueiredo-Carvalho, MHG; Ramos, LS; Zancopé-Oliveira, RM1
Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Prakash, A; Vaezi, A1
Chen, L; Dong, W; Dong, Y; Li, Y; Meng, T; Wang, X; Wang, Y; Xie, J; Xing, Y1
Chen, C; Chen, D; Kruger, E; Wan, X; Wang, L; Wu, J; Yue, X1
Bhattacharya, S; Fries, BC1
Adams-Chapman, I; Autmizguine, J; Benjamin, DK; Cohen-Wolkowiez, M; Cotten, CM; Goldberg, RN; Smith, PB; Stoll, BJ; Tan, S; Wiederhold, N1
Aurich, B; Barin-Le Guellec, C; Biran, V; Coopman, S; Dusang, B; Elie, V; Garcia Sanchez, R; Goudjil, S; Jacqz-Aigrain, E; Legrand, F; Leroux, S; Manzoni, P; Zhao, W1
Abebaw, Y; Bitew, A1
Andrade, VS; Boniek, D; Brandão, LDS; da Mata, FMR; de Azevedo, PRM; Fernandes, JV; Resende Stoianoff, MA1
Bal, AM; McGill, M1
El-Houssaini, HH; Elkhatib, WF; Elnabawy, OM; Nasser, HA1
Çakır, SÇ; Çelebi, S; Dorum, BA; Hacımustafaoğlu, M; Köksal, N; Özkan, H; Yeşil, E1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E1
Chaftari, AM; Hachem, R; Kontoyiannis, DP; Raad, II; Reitzel, RA; Rosenblatt, J; Vargas-Cruz, N; Wilson Dib, R1
Choi, DL; Joh, JW; Kang, WH; Kim, JD; Kim, JM; Kim, MS; Kwon, CHD; Lee, KW; Lee, SG; Song, GW; Suh, KS; Yi, NJ1
Angulo, D; Helou, S; Pappas, PG; Powderly, WG; Pullman, J; Spec, A; Thompson, GR; Tobin, EH; Vazquez, J; Wring, SA1
Agnelli, C; Bouza, E; Escribano, P; Guinea, J; Muñoz, P; Valerio, M1
Ahmad, S; Al-Sweih, N; Alfouzan, W; Joseph, L; Khan, Z1
Fujita, H; Fujiwara, SI; Fukuda, T; Gotoh, M; Iino, M; Jo, Y; Kanda, Y; Kimura, SI; Matsumura, I; Nakamura, S; Okamoto, A; Oyake, T; Saburi, Y; Sakaida, E; Shiratori, S; Takamatsu, Y; Tamura, K; Yamaguchi, H; Yamanouchi, J1
Ahmad, S; Al-Baqsami, ZF; Khan, Z1
Byun, JH; Choi, JH; Chun, HS; Han, EH; Jeong, Y; Kim, SH; Kim, YJ; Lee, SO; Park, C; Song, KY1
Chen, J; Chu, Y; Han, X; Shang, H; Tian, S; Wang, Q; Zhou, B1
Fitzgerald, LJ; Kauffman, CA; Linder, KA; Miceli, MH; Patel, TS; Richards, BJ1
Angiolella, L; D'Erme, M; Maggiore, A; Maras, B; Mignogna, G1
Farooqi, J; Jabeen, K; Memon, S; Naqvi, SF; Zafar, A; Zafar, U1
Aguado, JM; Alonso-Carrillo, J; Andrés, A; Fernández-Ruiz, M; González, E; Herrero-Martínez, JM; Jiménez, C; Justo, I; Loinaz, C; López-Medrano, F; Lumbreras, C; Manrique, A; Marcacuzco, A; Muñoz de la Espada, M; Pérez-Jacoiste Asín, MA; Rodríguez-Goncer, I; San Juan, R1
Cho, SI; Choi, SH; Kim, J; Kim, SY; Kim, WJ; Kim, YR; Koo, J; Lee, CH; Lee, H; Lee, HJ; Lee, HK; Oh, J; Ryu, SW; Shin, JH; Sohn, YH; Sung, GH1
Kim, HR; Kim, TH; Kweon, OJ; Lee, MK; Lim, YK1
Aksaray, S; Turan, D1
Abe, M; Hirabayashi, A; Hosaka, Y; Kajihara, T; Kitamura, N; Miyazaki, Y; Nagi, M; Sugai, M; Yahara, K1
Goto, N; Hida, Y; Higashi, T; Iwasaki, H; Kodawara, T; Tsukamoto, H; Watanabe, K1
Balázs, B; Balogh, B; Bozó, A; Forgács, L; Kelentey, B; Kovács, R; Majoros, L; Tóth, Z1
Chu, Y; Deng, J; Du, C; Hu, X; Ji, Q; Lang, X; Liu, L; Long, Y; Wu, H; Xu, Y; Yang, X1
He, C; Kang, W; Li, J; Wang, T; Xu, Y; Yu, J; Zhang, G; Zhang, J; Zhao, Y1
Edwin Erayil, S; Kline, SE; Scott, NE; Selmecki, A1

Reviews

24 review(s) available for fluconazole and micafungin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Candidiasis].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Antifungal Agents; beta-Glucans; Biomarkers; Candidiasis; Diagnosis, Differential; Echinocandins; Fluconazole; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Molecular Diagnostic Techniques; Peptides, Cyclic; Prognosis; Serologic Tests

2003
[Antifungal drug].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Design; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fluorouracil; Fungi; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Polyenes; Pyrimidines

2003
[Guidelines for the management of deep mycosis in neutropenic patients].
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2004, Volume: 45, Issue:4

    Topics: Amphotericin B; Aspergillosis; Candidiasis; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Micafungin; Neutropenia; Peptides, Cyclic; Practice Guidelines as Topic

2004
Combination antifungal therapy: where are we now, and where are we going?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2004
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005
[Drug-drug interaction of antifungal drugs].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:10

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Treatment of invasive candidal infections: systematic review and meta-analysis.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
[What's new in the molecular basis of antifungal drug resistance in pathogenic yeasts].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Mutation; Pyrimidines; Saccharomyces cerevisiae Proteins; Sterols; Trans-Activators; Triazoles; Voriconazole

2008
[Candidiasis].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; beta-Glucans; Biomarkers; Candida; Candidiasis; Diabetes Complications; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Proteoglycans

2008
[Clinical efficacies of antifungal injections].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole

2008
[Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
    Revista iberoamericana de micologia, 2009, Mar-31, Volume: 26, Issue:1

    Topics: Adult; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Echinocandins; Fluconazole; Forecasting; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Multicenter Studies as Topic; Mycoses; Organ Transplantation; Postoperative Complications; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Zygomycosis

2009
Traditional and emerging antifungal therapies.
    Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole

2010
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2011, Volume: 14, Issue:3

    Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Proteoglycans; Randomized Controlled Trials as Topic; Species Specificity; Treatment Outcome

2011
In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2

    Topics: Anidulafungin; Candida; Candidiasis; Caspofungin; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Glucosyltransferases; Humans; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity; Therapeutic Equivalency

2011
[Candidosis].
    Medical mycology journal, 2011, Volume: 52, Issue:1

    Topics: Antifungal Agents; Candidiasis; Catheters; Contraindications; Cross Infection; Disease Susceptibility; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Micafungin; Risk Factors; Transplantation

2011
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2012
Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Clinical therapeutics, 2014, Feb-01, Volume: 36, Issue:2

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Micafungin; Opportunistic Infections; Randomized Controlled Trials as Topic; Treatment Outcome

2014
Rare infection of implantable cardioverter-defibrillator lead with Candida albicans: case report and literature review.
    Therapeutic advances in cardiovascular disease, 2014, Volume: 8, Issue:5

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Defibrillators, Implantable; Echinocandins; Echocardiography; Endocarditis; Female; Fluconazole; Humans; Lipopeptides; Micafungin; Middle Aged; Prosthesis-Related Infections

2014
Dosing of antifungal agents in obese people.
    Expert review of anti-infective therapy, 2016, Volume: 14, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles

2016
Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:2

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Voriconazole

2016
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Future microbiology, 2016, Volume: 11

    Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole

2016
Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Antifungal Agents; Caspofungin; Cost-Benefit Analysis; Critical Illness; Echinocandins; Economics, Pharmaceutical; Fluconazole; Humans; Invasive Fungal Infections; Lipopeptides; Micafungin; Network Meta-Analysis; Primary Prevention

2017
Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris.
    BMC infectious diseases, 2020, Nov-11, Volume: 20, Issue:1

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Micafungin; Prevalence

2020

Trials

12 trial(s) available for fluconazole and micafungin

ArticleYear
A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Double-Blind Method; Echinocandins; Esophageal Diseases; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Peptides, Cyclic

2004
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Nov-15, Volume: 39, Issue:10

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Echinocandins; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Peptides, Cyclic

2004
Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Antifungal Agents; Area Under Curve; Bone Marrow Transplantation; Chemoprevention; Double-Blind Method; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Neoplasms; Peptides, Cyclic; Stem Cell Transplantation

2005
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
    Alimentary pharmacology & therapeutics, 2005, Apr-01, Volume: 21, Issue:7

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Double-Blind Method; Echinocandins; Esophageal Diseases; Female; Fluconazole; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Peptides, Cyclic; Treatment Outcome

2005
Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation.
    International journal of hematology, 2008, Volume: 87, Issue:1

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Echinocandins; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Transplantation, Homologous

2008
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation.
    International journal of hematology, 2008, Volume: 88, Issue:5

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Echinocandins; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Transplantation, Homologous

2008
[Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia in children undergoing chemotherapy and hematopoietic stem cell transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:12

    Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Male; Meropenem; Micafungin; Minocycline; Mycoses; Neutropenia; Opportunistic Infections; Organophosphates; Prodrugs; Thienamycins

2009
Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    The Journal of infection, 2016, Volume: 73, Issue:5

    Topics: Adult; Antifungal Agents; Echinocandins; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lipopeptides; Logistic Models; Male; Micafungin; Middle Aged; Pre-Exposure Prophylaxis; Republic of Korea; Risk Factors; Transplantation Conditioning; Treatment Outcome; Young Adult

2016
Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:9

    Topics: Age Factors; Animals; Antifungal Agents; Area Under Curve; Candidiasis; Female; Fluconazole; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Micafungin; Mice; Prospective Studies

2018
A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2020, Volume: 24, Issue:4

    Topics: Antifungal Agents; End Stage Liver Disease; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lipopeptides; Liver Transplantation; Living Donors; Micafungin; Middle Aged; Mycoses; Severity of Illness Index

2020
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.
    The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Candida; Candidiasis, Invasive; Echinocandins; Female; Fluconazole; Glycosides; Humans; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triterpenes

2019
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 03-10, Volume: 38, Issue:8

    Topics: Adult; Aged; Antifungal Agents; Febrile Neutropenia; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukocyte Count; Male; Micafungin; Middle Aged; Mycoses; Neutrophils; Young Adult

2020

Other Studies

115 other study(ies) available for fluconazole and micafungin

ArticleYear
Combined therapies in a murine model of blastoschizomycosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole

2007
In vitro antifungal susceptibilities of five species of sporothrix.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis

2008
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzamidines; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Specific Pathogen-Free Organisms; Treatment Outcome

2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity

2008
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged

2008
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies

2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain

2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia

2009
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4

    Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence

2010
T-2307 shows efficacy in a murine model of Candida glabrata infection despite in vitro trailing growth phenomena.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Male; Mice; Microbial Sensitivity Tests; Molecular Structure

2010
Design, synthesis, and biological evaluation of novel spiro[pyrrolidine-2,3'-quinolin]-2'-one derivatives as potential chitin synthase inhibitors and antifungal agents.
    European journal of medicinal chemistry, 2022, Apr-05, Volume: 233

    Topics: Antifungal Agents; Candida albicans; Chitin; Chitin Synthase; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Pyrrolidines; Structure-Activity Relationship

2022
In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
    The Journal of antibiotics, 2000, Volume: 53, Issue:10

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Drug Resistance, Microbial; Echinocandins; Fluconazole; Fungi; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Reference Standards

2000
[Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122, Issue:4

    Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic

2003
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
    The Japanese journal of antibiotics, 2003, Volume: 56, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors

2003
The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Die Pharmazie, 2004, Volume: 59, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Thiazoles

2004
Fluconazole-resistant pathogens Candida inconspicua and C. norvegensis: DNA sequence diversity of the rRNA intergenic spacer region, antifungal drug susceptibility, and extracellular enzyme production.
    Microbiology and immunology, 2004, Volume: 48, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspartic Acid Endopeptidases; Base Sequence; Candida; DNA, Ribosomal Spacer; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genetic Variation; Lipopeptides; Lipoproteins; Lysophospholipase; Micafungin; Molecular Sequence Data; Peptides, Cyclic; RNA, Ribosomal; Virulence

2004
Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Cyclophosphamide; Drug Therapy, Combination; Echinocandins; Fluconazole; Immunosuppressive Agents; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Peptides, Cyclic; Trichosporon

2005
Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:4

    Topics: Animals; Antifungal Agents; Candidiasis; Cyclophosphamide; Dose-Response Relationship, Drug; Echinocandins; Female; Fluconazole; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Lipoproteins; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peptides, Cyclic; Specific Pathogen-Free Organisms

2005
Choosing a study population for the evaluation of antifungal prophylaxis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-01, Volume: 40, Issue:11

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Peptides, Cyclic

2005
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:11

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Echinocandins; Fluconazole; Flucytosine; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Peptides, Cyclic

2005
Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy.
    European journal of cancer care, 2006, Volume: 15, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cohort Studies; Cost-Benefit Analysis; Echinocandins; Fluconazole; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Opportunistic Infections; Peptides, Cyclic

2006
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic

2006
[Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
    Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology, 2005, Volume: 16, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Japan; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Minimally Invasive Surgical Procedures; Peptides, Cyclic

2005
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
    Biochemical and biophysical research communications, 2006, Aug-25, Volume: 347, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity

2006
Candin family antifungal agent micafungin (FK463) modulates the inflammatory cytokine production stimulated by lipopolysaccharide in THP-1 cells.
    Translational research : the journal of laboratory and clinical medicine, 2006, Volume: 148, Issue:4

    Topics: Antifungal Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Gene Expression; Humans; Interleukin-8; Lipopeptides; Lipopolysaccharides; Lipoproteins; Macrophages; Micafungin; Monocytes; Peptides, Cyclic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha

2006
Combined antifungal therapy in a murine infection by Candida glabrata.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic; Spleen; Survival Analysis

2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole

2006
Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
    Cornea, 2007, Volume: 26, Issue:3

    Topics: Animals; Antifungal Agents; Candidiasis; Conjunctiva; Disease Models, Animal; Echinocandins; Eye Infections, Fungal; Fluconazole; Injections; Keratitis; Lipopeptides; Lipoproteins; Male; Micafungin; Peptides, Cyclic; Rabbits

2007
Acquired resistance to echinocandins in Candida albicans: case report and review.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:6

    Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2007
In vitro interaction of micafungin and fluconazole against Candida.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic

2007
Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Cell Adhesion; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Fungal Proteins; Host-Pathogen Interactions; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Phenotype; Rats; Rats, Wistar; Virulence

2008
Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:4

    Topics: Animals; Antifungal Agents; Blastomycosis; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fluconazole; Kidney; Lipopeptides; Lipoproteins; Liver; Male; Micafungin; Mice; Microbial Sensitivity Tests; Spleen; Survival Analysis

2008
Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2008, Volume: 105, Issue:4

    Topics: Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Head and Neck Neoplasms; HIV Infections; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests

2008
Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
    Clinical therapeutics, 2008, Volume: 30, Issue:5

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cost-Benefit Analysis; Echinocandins; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses

2008
Ocular distribution of intravenously administered micafungin in rabbits.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2008, Volume: 14, Issue:3

    Topics: Animals; Antifungal Agents; Echinocandins; Endophthalmitis; Eye; Female; Fluconazole; Infusions, Intravenous; Lipopeptides; Lipoproteins; Micafungin; Rabbits

2008
Micafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:3

    Topics: Antifungal Agents; Arthroplasty, Replacement, Knee; Biofilms; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Humans; Knee Prosthesis; Lipopeptides; Micafungin; Middle Aged; Prosthesis-Related Infections

2009
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole

2009
Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Clinical therapeutics, 2009, Volume: 31, Issue:5

    Topics: Adult; Antifungal Agents; Chemoprevention; Cohort Studies; Cost-Benefit Analysis; Decision Trees; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Korea; Lipopeptides; Micafungin; Mycoses; Odds Ratio; Treatment Outcome

2009
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation.
    Critical care (London, England), 2009, Volume: 13, Issue:3

    Topics: Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Cross Infection; Decision Trees; Drug Costs; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungemia; Humans; Incidence; Intensive Care Units; Lipopeptides; Micafungin; Models, Econometric; Monte Carlo Method; Quality-Adjusted Life Years

2009
Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
    Critical care (London, England), 2009, Volume: 13, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Clinical Protocols; Echinocandins; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Micafungin; Sepsis

2009
Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy.
    The American journal of the medical sciences, 2010, Volume: 339, Issue:2

    Topics: Aged; Antifungal Agents; Candidiasis; Cardiomyopathy, Hypertrophic; Echinocandins; Endocarditis; Female; Fluconazole; Humans; Kidney Neoplasms; Lipopeptides; Micafungin

2010
The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis.
    The British journal of ophthalmology, 2011, Volume: 95, Issue:10

    Topics: Administration, Topical; Aged; Antifungal Agents; Candida; Candidiasis; Cornea; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Female; Fluconazole; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Ophthalmic Solutions; Prospective Studies; Treatment Outcome; Visual Acuity

2011
Physical compatibility of 4% sodium citrate with 23.4% sodium chloride, fluconazole, and micafungin.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Mar-01, Volume: 68, Issue:5

    Topics: Anticoagulants; Antifungal Agents; Catheter-Related Infections; Citrates; Drug Incompatibility; Drug Stability; Drug Storage; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Saline Solution, Hypertonic; Sodium Citrate; Temperature

2011
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts

2011
Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; beta-Glucans; Echinocandins; Female; Fluconazole; Fungemia; Hematologic Diseases; Humans; Immunocompromised Host; Lipopeptides; Male; Micafungin; Miconazole; Middle Aged; Proteoglycans; Retrospective Studies; Treatment Outcome; Trichosporon; Young Adult

2012
Functional characterization of the regulators of calcineurin in Candida glabrata.
    FEMS yeast research, 2011, Volume: 11, Issue:8

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Intracellular Signaling Peptides and Proteins; Lipopeptides; Micafungin; Molecular Sequence Data; RNA, Fungal; RNA, Messenger; Saccharomyces cerevisiae; Sequence Alignment; Sequence Deletion; Signal Transduction; Stress, Physiological; Tunicamycin

2011
Candida albicans prosthetic shoulder joint infection in a patient with rheumatoid arthritis on multidrug therapy.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:1

    Topics: Aged; Antifungal Agents; Arthritis, Rheumatoid; Candida albicans; Candidiasis; Diabetes Complications; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Humans; Immunosuppressive Agents; Joint Prosthesis; Lipopeptides; Micafungin; Prosthesis-Related Infections; Shoulder Joint

2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
In vitro efficacy of continuous mild heat stress on the antifungal susceptibility of Candida albicans biofilm formation.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Echinocandins; Fluconazole; Hot Temperature; Lipopeptides; Micafungin; Stress, Physiological

2012
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2012
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2012, Volume: 86, Issue:2 Suppl 4

    Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Echinocandins; Feces; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices

2012
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
    The Japanese journal of antibiotics, 2012, Volume: 65, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Antifungal Agents; Biofilms; Candida albicans; Echinocandins; Ergosterol; Fluconazole; Glucans; Hyphae; Kinetics; Lipopeptides; Micafungin; Microscopy; Time-Lapse Imaging

2013
Characterization of biofilms in drug-sensitive and drug-resistant strains of Candida albicans.
    Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:2

    Topics: Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin

2013
Micafungin versus fluconazole for prophylaxis against fungal infections in premature infants.
    Pediatrics international : official journal of the Japan Pediatric Society, 2013, Volume: 55, Issue:6

    Topics: Antifungal Agents; Echinocandins; Female; Fluconazole; Historically Controlled Study; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Male; Micafungin; Mycoses

2013
Endocarditis caused by Candida dubliniensis.
    The American journal of the medical sciences, 2013, Volume: 346, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Endocarditis; Fluconazole; Humans; Lipopeptides; Male; Micafungin; Middle Aged

2013
De-escalation from micafungin is a cost-effective alternative to traditional escalation from fluconazole in the treatment of patients with systemic Candida infections.
    Journal of medical economics, 2013, Volume: 16, Issue:11

    Topics: Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Decision Support Techniques; Echinocandins; Fluconazole; Health Services; Humans; Life Expectancy; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Quality-Adjusted Life Years

2013
Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:18

    Topics: Aged, 80 and over; Antifungal Agents; Candidemia; Catheter-Related Infections; Central Venous Catheters; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Humans; Jugular Veins; Lipopeptides; Micafungin; Organophosphates; Recurrence; Thrombophlebitis; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color

2013
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2013
EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.
    Mycoses, 2014, Volume: 57, Issue:6

    Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Echinocandins; Europe; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests

2014
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
    BMC oral health, 2014, Feb-20, Volume: 14

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia

2014
Anidulafungin-induced alopecia.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:5

    Topics: Adult; Alopecia; Anidulafungin; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Micafungin

2014
Antifungal susceptibility of Candida isolates at one institution.
    Medical mycology journal, 2014, Volume: 55, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole

2014
Fungemia due to Lachancea fermentati: a case report.
    BMC infectious diseases, 2014, May-10, Volume: 14

    Topics: Adult; Antifungal Agents; Echinocandins; Fluconazole; Fungemia; Hepatitis, Alcoholic; Humans; Immunocompromised Host; Lipopeptides; Male; Micafungin; Peritonitis; Yeasts

2014
Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; United States

2014
Glutathione metabolism in Candida albicans resistant strains to fluconazole and micafungin.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glutathione; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Oxidation-Reduction

2014
Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study.
    Clinical therapeutics, 2014, Sep-01, Volume: 36, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidemia; Colony Count, Microbial; Controlled Before-After Studies; Echinocandins; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Micafungin; Middle Aged; Numbers Needed To Treat; Pilot Projects; Retrospective Studies; Shock, Septic; Time Factors

2014
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidemia; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Health Care Costs; Hospitalization; Humans; Infant; Intensive Care Units; Lipopeptides; Male; Micafungin; Middle Aged; Treatment Outcome; Young Adult

2015
Successful treatment of Cryptococcus laurentii peritonitis in a patient on peritoneal dialysis.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:8

    Topics: Adult; Antifungal Agents; Catheterization; Catheters, Indwelling; Cryptococcus; Device Removal; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Micafungin; Mycoses; Peritoneal Dialysis; Peritonitis

2015
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
    BMC infectious diseases, 2015, Jul-03, Volume: 15

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole

2015
In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida glabrata; Candida tropicalis; Echinocandins; Fluconazole; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests

2015
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole

2015
Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis.
    BMC infectious diseases, 2015, Oct-26, Volume: 15

    Topics: Anidulafungin; Antifungal Agents; Candidemia; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Drug Costs; Echinocandins; Fluconazole; Humans; Intensive Care Units; Length of Stay; Lipopeptides; Micafungin; Models, Economic; Treatment Outcome; United Kingdom

2015
Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.
    Mycoses, 2016, Volume: 59, Issue:3

    Topics: Administration, Intravenous; Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Critical Illness; Echinocandins; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Micafungin; Middle Aged; Multivariate Analysis; Retrospective Studies

2016
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole

2016
Opioid Dependent Malingerer with Self-Induced Sepsis.
    The western journal of emergency medicine, 2016, Volume: 17, Issue:6

    Topics: Analgesics, Opioid; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Echinocandins; Emergency Service, Hospital; Female; Fluconazole; Humans; Lipopeptides; Malingering; Micafungin; Opioid-Related Disorders; Sepsis; Staphylococcal Infections; Young Adult

2016
Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
    Journal of medical microbiology, 2016, Volume: 65, Issue:12

    Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Respiratory System; Urine

2016
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
    Mycoses, 2017, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Echinocandins; Female; Fluconazole; Fungemia; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Registries; Saccharomycetales; Voriconazole; Young Adult

2017
Changing epidemiology of candidaemia in Australia.
    The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4

    Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole

2017
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.
    BMC infectious diseases, 2017, 07-10, Volume: 17, Issue:1

    Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidemia; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Echinocandins; Economics, Pharmaceutical; Fluconazole; Humans; Lipopeptides; Micafungin; Taiwan; Treatment Outcome

2017
Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Biological Transport; Candida; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Lipopeptides; Micafungin; Microbial Sensitivity Tests

2017
Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of
    Mediators of inflammation, 2017, Volume: 2017

    Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Hydrolysis; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Virulence

2017
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11

    Topics: Antifungal Agents; Candida; Caspofungin; Drug Interactions; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; Voriconazole

2017
Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for invasive candidiasis in China.
    Journal of medical economics, 2018, Volume: 21, Issue:3

    Topics: Antifungal Agents; Candidemia; Candidiasis, Invasive; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Survival

2018
Enhanced Efflux Pump Activity in Old Candida glabrata Cells.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:3

    Topics: Amphotericin B; Antifungal Agents; ATP-Binding Cassette Transporters; Biological Transport; Candida glabrata; Cell Division; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genes, MDR; Glucosyltransferases; Micafungin; Microbial Sensitivity Tests

2018
Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.
    The Pediatric infectious disease journal, 2018, Volume: 37, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Cohort Studies; Drug Resistance, Fungal; Female; Fluconazole; Gestational Age; Humans; Infant; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Male; Micafungin; Microbial Sensitivity Tests; Neurodevelopmental Disorders; Prospective Studies; Sepsis; Treatment Outcome

2018
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
    BMC women's health, 2018, 06-15, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Ethiopia; Female; Fluconazole; Flucytosine; Humans; Micafungin; Microbial Sensitivity Tests; Middle Aged; Prevalence; Reproductive Tract Infections; Sexual Partners; Voriconazole; Young Adult

2018
Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil.
    Letters in applied microbiology, 2018, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Brazil; Candida; Candida glabrata; Candidiasis, Vulvovaginal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications; Prevalence; Schools; Young Adult

2018
Rapid species identification of Candida directly from blood culture broths by Sepsityper-MALDI-TOF mass spectrometry: impact on antifungal therapy.
    The journal of the Royal College of Physicians of Edinburgh, 2018, Volume: 48, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Blood Culture; Candida; Candidemia; Cost Savings; Female; Fluconazole; Humans; Male; Micafungin; Middle Aged; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors

2018
Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients.
    BMC infectious diseases, 2019, Jan-16, Volume: 19, Issue:1

    Topics: Antifungal Agents; Aspartic Acid Proteases; Biofilms; Candida albicans; Egypt; Fluconazole; Fungal Proteins; Humans; Hydrolases; Micafungin; Microbial Sensitivity Tests; Nystatin; Phospholipases; Virulence Factors

2019
[Results of the use of micafungin in newborns].
    Mikrobiyoloji bulteni, 2019, Volume: 53, Issue:1

    Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Micafungin; Retrospective Studies; Treatment Outcome

2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Scientific reports, 2019, 03-07, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult

2019
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Caspofungin; Catheter-Related Infections; Catheters; Citric Acid; Ethanol; Fluconazole; Micafungin; Nitroglycerin; Pharmaceutical Solutions; Voriconazole

2019
Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32, Issue:4

    Topics: Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Micafungin; Prosthesis-Related Infections; Recurrence

2019
Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
    Mycoses, 2020, Volume: 63, Issue:1

    Topics: Antifungal Agents; Candida; Candidemia; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fluconazole; Genes, Fungal; Humans; Kuwait; Micafungin; Microbial Sensitivity Tests; Pathology, Molecular; Voriconazole

2020
Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Scientific reports, 2020, 04-10, Volume: 10, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidemia; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Fungal Proteins; Glucosyltransferases; Humans; Kuwait; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Phylogeny; Sequence Deletion

2020
Fungal arthritis with adjacent osteomyelitis caused by Candida pelliculosa: a case report.
    BMC infectious diseases, 2020, Jun-22, Volume: 20, Issue:1

    Topics: Aged; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Candida; Candidemia; Candidiasis; Deoxycholic Acid; Device Removal; Drug Combinations; Female; Fluconazole; Humans; Intraoperative Care; Joint Prosthesis; Knee; Micafungin; Osteomyelitis

2020
Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:1

    Topics: Antifungal Agents; Fluconazole; Humans; Invasive Fungal Infections; Lung Transplantation; Micafungin

2021
Hyperexpression of CDRs and HWP1 genes negatively impacts on Candida albicans virulence.
    PloS one, 2021, Volume: 16, Issue:6

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Gene Expression; Gene Expression Regulation, Fungal; Humans; Hyphae; Larva; Lepidoptera; Membrane Glycoproteins; Membrane Transport Proteins; Micafungin; Microbial Sensitivity Tests; Phenotype; Virulence

2021
Antifungal susceptibility profile of invasive
    Journal of medical microbiology, 2021, Volume: 70, Issue:12

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Micafungin; Pakistan; Retrospective Studies; Tertiary Care Centers

2021
Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods.
    Mycoses, 2022, Volume: 65, Issue:5

    Topics: Adult; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Female; Fluconazole; Humans; Male; Micafungin; Middle Aged; Pancreas; Pancreas Transplantation; Retrospective Studies; Transplant Recipients

2022
Comparison of Six Antifungal Susceptibilities of 11
    Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Caspofungin; Drug Resistance, Fungal; Fluconazole; Micafungin; Microbial Sensitivity Tests; Voriconazole

2022
Comparison of simulated candidemia detection during prophylactic antifungal therapy.
    Diagnostic microbiology and infectious disease, 2022, Volume: 104, Issue:2

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidemia; Caspofungin; Fluconazole; Humans; Micafungin; Microbial Sensitivity Tests

2022
[One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?]
    Mikrobiyoloji bulteni, 2022, Volume: 56, Issue:3

    Topics: Anidulafungin; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Micafungin; Microbial Sensitivity Tests; Mycology; Voriconazole

2022
Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010-2019: A retrospective observational study based on national surveillance data.
    Medical mycology, 2022, Sep-29, Volume: 60, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Fluconazole; Humans; Japan; Micafungin; Microbial Sensitivity Tests; Voriconazole

2022
A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022, Volume: 41, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candidemia; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Japan; Longitudinal Studies; Micafungin; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole

2022
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
    Mycopathologia, 2023, Volume: 188, Issue:1-2

    Topics: Amphotericin B; Anidulafungin; Biofilms; Caspofungin; Echinocandins; Fluconazole; Micafungin

2023
Design, synthesis and biological evaluation of novel spiro-quinazolinone derivatives as chitin synthase inhibitors and antifungal agents.
    European journal of medicinal chemistry, 2023, Jul-05, Volume: 255

    Topics: Antifungal Agents; Chitin; Chitin Synthase; Drug Design; Enzyme Inhibitors; Fluconazole; Fungi; Humans; Micafungin; Microbial Sensitivity Tests; Molecular Docking Simulation; Quinazolinones; Structure-Activity Relationship

2023
Rapid automated antifungal susceptibility testing system for yeasts based on growth characteristics.
    Frontiers in cellular and infection microbiology, 2023, Volume: 13

    Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Fluconazole; Micafungin; Microbial Sensitivity Tests; Reproducibility of Results; Voriconazole; Yeasts

2023
Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy.
    Antimicrobial agents and chemotherapy, 2023, 08-17, Volume: 67, Issue:8

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple; Echinocandins; Fluconazole; Humans; Micafungin; Microbial Sensitivity Tests

2023